CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Desloratadinedrug
Likely dose
Desloratadine 2.5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00723736
NCT00723736N/ACompleted
CompareCT.gov

Non-Interventional Study of the Safe Use of Aerius in Pediatric Patients With Allergic Rhinitis or Chronic Idiopathic Urticaria.

Organon and Co·observational·Posted Jul 29, 2008·Updated Feb 9, 2022

In Brief

An observational study evaluating Desloratadine for Rhinitis and Urticaria. Completed, enrolled 100 participants.

Detailed Summary

The objective of this non-interventional study is to evaluate the safety of Aerius syrup in pediatric patients aged 1-5 years old with allergic rhinitis or chronic idiopathic uticaria. The patients will receive 2.5 ml (1.25 mg) once daily.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRhinitis, Urticaria
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 29, 2008
Enrollment StartDec 1, 2007
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 17.9 years ago

Interventions

Desloratadinedrug

2.5 ml (1.25 mg) once daily